Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps. Zhu R, Owen R, Wilkins J, Schoemaker R, et al. Pulm Pharmacol Ther 2021;71:102080.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu R, Owen R, Wilkins J, Schoemaker R, et al. Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps. Pulm Pharmacol Ther 2021;71:102080.
PMID: 34592476